Minerva Neurosciences names board member
This article was originally published in Scrip
Executive Summary
Waltham, Massachusetts-based Minerva Neurosciences has named Dr Fouzia Laghrissi-Thode to its board of directors. In the past, Dr Laghrissi-Thode has held positions of leadership at AstraZeneca, Roche, Novartis and Sandoz in a broad range of therapeutic areas, including central nervous system, cardiovascular, metabolic disease and genito-urinary health. She is currently vice-president of the cardiovascular and metabolism therapy area at AstraZeneca.